TTK Healthcare Q4 Results
- BSE: 507747
- NSE: TTKHLTCARE
- ISIN: INE910C01018
- Sector: Biotechnology & Drugs
BSE
922.00
5.70 (0.62%)
5.70 (0.62%)Volume190.00
Updated: Fri 10 Jul, 2026 | 15:09:48
NSE
9255.95 (0.65%)
5.95 (0.65%)Volume5.55 K
Updated: Fri 10 Jul, 2026 | 15:29:59
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
- Total Income₹217.98 Cr.(14.51%)
- Operating Profit₹12.40 Cr.(212.06%)
- Profit After Tax₹21.76 Cr.(34.76%)
- Operating Margin5.69%(172.51%)
Note: Comparison is on YoY basis
Quarterly - TTK Healthcare Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 26 | Dec 25 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 205.59 | 211.96 | -3.01% | 171.96 | 10.30% |
| Depreciation/ Amortization | 2.14 | 2.22 | -3.75% | 3.32 | -1.33% |
| Operating Income | 12.40 | -2.66 | 0.00% | 9.10 | 212.06% |
| Net Income | 21.76 | 10.53 | 106.62% | 18.27 | 34.76% |
| Other Operating Expenses Total | 59.76 | 62.82 | -4.87% | 52.41 | 9.75% |
| Net Income Before Taxes | 29.53 | 14.09 | 109.59% | 24.23 | 35.71% |
| Total Revenue | 217.98 | 209.30 | 4.15% | 181.06 | 14.51% |
| Selling/ General/ Admin Expenses Total | 40.99 | 41.73 | -1.76% | 32.24 | 12.62% |
| Diluted Normalized EPS | 13.58 | 11.46 | 18.48% | 12.93 | -6.44% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.